1.32
price down icon1.49%   -0.02
after-market After Hours: 1.29 -0.03 -2.27%
loading

Avenue Therapeutics Inc Stock (ATXI) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Research and Development
143.58%
2.392
0.982 0.907 3.027 1.215
Operating Income/Loss
74.99%
-3.708
-2.119 -2.068 -3.923 -6.429
Nonoperating Income/Loss
-0.641
- 2.581 -0.093 -1.173
Income/Loss From Continuing Operations Before Tax
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Income/Loss From Continuing Operations After Tax
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Net Income/Loss
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
60.87%
-0.009
-0.023 -0.013 -0.009 -0.066
Basic Average Shares
83.65%
0.562
3.4366 8.1142 - 5.5648
Basic Earnings Per Share
2,850%
-15.40
0.56 0.06 -0.52 -1.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):